Anatomo-radiological correlation in breast cancer response to neoadjuvant chemotherapy according to histological and molecular subtypes.

Congress:

ECR 2021

Poster Number:

C-10320

Type:

Scientific Exhibit

Keywords:

Breast, MR, Treatment effects, Cancer, Molecular, genomics and proteomics, Multidisciplinary cancer care

Authors:

I. Mendoza Arnau, M. D. Rabadán Caravaca, M. Culiañez Casas, S. Martínez Meca; Granada/ES

DOI:

10.26044/ecr2021/C-10320

DOI-Link:

https://dx.doi.org/10.26044/ecr2021/C-10320

References

Claudette E, Loo M,Straver E. Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype. J Clin Oncol. 2011 Feb 20;29(6):660-6.
Gu YL, Pan SM, Ren J. Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis. Clin Breast Cancer. 2017 Jul;17(4): 245-255
Lobbes MB, Prevos R, Smidt M.The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy:a systematic review. Insights Imaging. 2013 Apr;4(2):163-75.
Zhang X,Wand D, Liu Z.The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer. Quant Imaging Med Surg. 2020 Jan;(1):197-210.
Yu N, Leung VWY, Meterissian S. MRI Performance in Detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer. World J Surg. 2019 Sep;43(9):2254-226.

Fig 1: Fig. 1. Radiological response in MRI assessment to neoadjuvant chemotherapy...

Fig 2: Fig. 2. Complete response: absence of enhancement in subtraction sequences...

Fig 3: Fig. 3. Concentric morphological response: circumferential decreasing from the...

Fig 4: Fig. 4. Concentric morphological response: tumor decreases from the periphery...

Fig 5: Fig. 5. Mixed morphological response. Decreasing of the tumor from the...

Fig 6: Fig. 6. Pre- NAC breast MRI (A): BI-RADS 6 lesion with type 2 signal intensity...

Fig 7: Fig. 7. Complete radiological response corresponding to a grade 5 of pathologic...

Fig 8: Fig. 8. Minor partial radiological response corresponding to a grade 1 of...

Fig 9: Fig. 9. Percentage of histological and molecular subtypes.

Fig 10: Fig. 10. Percentaje of radiological (A) and pathologic response (B).

Fig 11: Fig. 11. Correlation between radiological and pathologic response according to...